Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2

Alessandra Greco, Sara Plumitallo, Laura Scelsi, Giannantonio Maggi, Matteo Sobrero, Annalisa Turco, Claudia Raineri, Natalia Arseni, Donata Cappelletti, Luigi Oltrona Visconti, Fabio Pagella, Giuseppe Spinozzi, Stefano Ghio, Carla Olivieri, Cesare Danesino

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Hereditary hemorrhagic telangiectasia (HTT) is an autosomal dominant disease, most frequently caused by a mutation in either ENG or ACVRL1, which can be associated with pulmonary arterial hypertension (PAH). In this report, we describe a new unpublished ACVRL1 mutation segregating in three members of the same family, showing three different types of pulmonary hypertension (PH) in the absence of BMPR2 mutations. The first patient has a form of heritable PAH (HPAH) in the absence of hepatic arteriovenous malformations (AVMs); the second one has a severe form of portopulmonary hypertension (PoPAH) associated with multiple hepatic AVMs; the third one has hepatopulmonary syndrome (HPS) with numerous hepatic arteriovenous fistulas and a form of post-capillary PH due to high cardiac output. In summary, a single mutation in the ACVRL1 gene can be associated, in the same family, with an extreme phenotypic variability regarding not only the clinical presentation of HHT but also the type of PH in the absence of BMPR2 mutations. More studies are needed to evaluate if this variability can be explained by the presence of additional variants in other genes relevant for the pathogenesis of HHT.

Original languageEnglish
JournalPulmonary Circulation
Volume8
Issue number4
DOIs
Publication statusPublished - Oct 1 2018
Externally publishedYes

Fingerprint

Pulmonary Hypertension
Mutation
Arteriovenous Malformations
Liver
Hepatopulmonary Syndrome
High Cardiac Output
Hereditary Hemorrhagic Telangiectasia
Arteriovenous Fistula
Genes
Hypertension

Keywords

  • ACVRL1
  • hepatic arteriovenous malformations
  • hepatopulmonary syndrome
  • Hereditary hemorrhagic telangiectasia
  • pulmonary arterial hypertension

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2. / Greco, Alessandra; Plumitallo, Sara; Scelsi, Laura; Maggi, Giannantonio; Sobrero, Matteo; Turco, Annalisa; Raineri, Claudia; Arseni, Natalia; Cappelletti, Donata; Visconti, Luigi Oltrona; Pagella, Fabio; Spinozzi, Giuseppe; Ghio, Stefano; Olivieri, Carla; Danesino, Cesare.

In: Pulmonary Circulation, Vol. 8, No. 4, 01.10.2018.

Research output: Contribution to journalArticle

@article{d631324b60a84f4f8d87020dadf45a24,
title = "Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2",
abstract = "Hereditary hemorrhagic telangiectasia (HTT) is an autosomal dominant disease, most frequently caused by a mutation in either ENG or ACVRL1, which can be associated with pulmonary arterial hypertension (PAH). In this report, we describe a new unpublished ACVRL1 mutation segregating in three members of the same family, showing three different types of pulmonary hypertension (PH) in the absence of BMPR2 mutations. The first patient has a form of heritable PAH (HPAH) in the absence of hepatic arteriovenous malformations (AVMs); the second one has a severe form of portopulmonary hypertension (PoPAH) associated with multiple hepatic AVMs; the third one has hepatopulmonary syndrome (HPS) with numerous hepatic arteriovenous fistulas and a form of post-capillary PH due to high cardiac output. In summary, a single mutation in the ACVRL1 gene can be associated, in the same family, with an extreme phenotypic variability regarding not only the clinical presentation of HHT but also the type of PH in the absence of BMPR2 mutations. More studies are needed to evaluate if this variability can be explained by the presence of additional variants in other genes relevant for the pathogenesis of HHT.",
keywords = "ACVRL1, hepatic arteriovenous malformations, hepatopulmonary syndrome, Hereditary hemorrhagic telangiectasia, pulmonary arterial hypertension",
author = "Alessandra Greco and Sara Plumitallo and Laura Scelsi and Giannantonio Maggi and Matteo Sobrero and Annalisa Turco and Claudia Raineri and Natalia Arseni and Donata Cappelletti and Visconti, {Luigi Oltrona} and Fabio Pagella and Giuseppe Spinozzi and Stefano Ghio and Carla Olivieri and Cesare Danesino",
year = "2018",
month = "10",
day = "1",
doi = "10.1177/2045894018782664",
language = "English",
volume = "8",
journal = "Pulmonary Circulation",
issn = "2045-8932",
publisher = "University of Chicago Press",
number = "4",

}

TY - JOUR

T1 - Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2

AU - Greco, Alessandra

AU - Plumitallo, Sara

AU - Scelsi, Laura

AU - Maggi, Giannantonio

AU - Sobrero, Matteo

AU - Turco, Annalisa

AU - Raineri, Claudia

AU - Arseni, Natalia

AU - Cappelletti, Donata

AU - Visconti, Luigi Oltrona

AU - Pagella, Fabio

AU - Spinozzi, Giuseppe

AU - Ghio, Stefano

AU - Olivieri, Carla

AU - Danesino, Cesare

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Hereditary hemorrhagic telangiectasia (HTT) is an autosomal dominant disease, most frequently caused by a mutation in either ENG or ACVRL1, which can be associated with pulmonary arterial hypertension (PAH). In this report, we describe a new unpublished ACVRL1 mutation segregating in three members of the same family, showing three different types of pulmonary hypertension (PH) in the absence of BMPR2 mutations. The first patient has a form of heritable PAH (HPAH) in the absence of hepatic arteriovenous malformations (AVMs); the second one has a severe form of portopulmonary hypertension (PoPAH) associated with multiple hepatic AVMs; the third one has hepatopulmonary syndrome (HPS) with numerous hepatic arteriovenous fistulas and a form of post-capillary PH due to high cardiac output. In summary, a single mutation in the ACVRL1 gene can be associated, in the same family, with an extreme phenotypic variability regarding not only the clinical presentation of HHT but also the type of PH in the absence of BMPR2 mutations. More studies are needed to evaluate if this variability can be explained by the presence of additional variants in other genes relevant for the pathogenesis of HHT.

AB - Hereditary hemorrhagic telangiectasia (HTT) is an autosomal dominant disease, most frequently caused by a mutation in either ENG or ACVRL1, which can be associated with pulmonary arterial hypertension (PAH). In this report, we describe a new unpublished ACVRL1 mutation segregating in three members of the same family, showing three different types of pulmonary hypertension (PH) in the absence of BMPR2 mutations. The first patient has a form of heritable PAH (HPAH) in the absence of hepatic arteriovenous malformations (AVMs); the second one has a severe form of portopulmonary hypertension (PoPAH) associated with multiple hepatic AVMs; the third one has hepatopulmonary syndrome (HPS) with numerous hepatic arteriovenous fistulas and a form of post-capillary PH due to high cardiac output. In summary, a single mutation in the ACVRL1 gene can be associated, in the same family, with an extreme phenotypic variability regarding not only the clinical presentation of HHT but also the type of PH in the absence of BMPR2 mutations. More studies are needed to evaluate if this variability can be explained by the presence of additional variants in other genes relevant for the pathogenesis of HHT.

KW - ACVRL1

KW - hepatic arteriovenous malformations

KW - hepatopulmonary syndrome

KW - Hereditary hemorrhagic telangiectasia

KW - pulmonary arterial hypertension

UR - http://www.scopus.com/inward/record.url?scp=85055026649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055026649&partnerID=8YFLogxK

U2 - 10.1177/2045894018782664

DO - 10.1177/2045894018782664

M3 - Article

AN - SCOPUS:85055026649

VL - 8

JO - Pulmonary Circulation

JF - Pulmonary Circulation

SN - 2045-8932

IS - 4

ER -